KDM5B and melanoma: Purified cells expressing JARID1B, a histone demethylase considered to be a melanoma CSC marker, generated JARID1B-negative cells, as expected by the CSC model; however, a single JARID1B-negative cell could also give rise to JARID1B-positive cells [15].